KRAS and disorder of glycogen metabolism: An activating somatic mutation in the KRAS proto-oncogene (G12V) was identified in a patient with GSD (172), and a mouse model was developed for GSD that revealed lymphatic developmental defects with fewer lymphatic valves (172).